Research Article Details
| Article ID: | A27332 |
| PMID: | 18630587 |
| Source: | Zhen Ci Yan Jiu |
| Title: | [Influence of electroacupuncture on insulin-resistance in nonalcoholic fatty liver rats]. |
| Abstract: | OBJECTIVE: To investigate the mechanism of electroacupuncture (EA) in treating nonalcoholic fatty liver disease (NAFLD) in rats. METHODS: Thirty male SD rats were randomized into normal control, NAFLD model and EA groups, with 10 cases in each. NAFLD model was established by feeding the rats with high-fat food for 8 weeks. EA (2 Hz, 4 mA) was applied to "Zusanli" (ST 36), "Fenglong" (ST 40), "Sanyinjiao" (SP 6), and "Taichong" (LR 3) for 15 min, once daily for 4 weeks. Fasting blood sugar (FBG) and serum free fatty acids (FFA) were detected with chromatometry; serum insulin (INS) was determined with radioimmunoassay; homeostasis model assessment insulin resistance (HOMA-IR) and liver index (LI) were calculated. Liver tissue was cut into sections for detecting pathological changes. RESULTS: Compared with normal control group, FBG, INS, FFA, HOMA-IR and LI of model group increased significantly (P<0.05), and hepatic diffuse steatosis with cellular necrosis and inflammatory cell infiltration was obvious. In comparison with model group, all the 5 indexes in EA group decreased significantly (P<0.05), and pathological changes as hepatic steatosis, etc. were significantly reduced. CONCLUSION: EA may be used to effectively improve NAFLD by lowering insulin resistance. |
| DOI: |
| Strategy ID | Therapy Strategy | Synonyms | Therapy Targets | Therapy Drugs | |
|---|---|---|---|---|---|
| S01 | Improve insulin resistance | insulin sensitizer; insulin resistance; glucose tolerance | Biguanide: increases 5-AMP activated protein kinase signaling; SGLT-2 inhibitor; Thiazalidinedione: selective PPAR-γ agonists; GLP-1 agonist | Metformin; Empagliflozin; Canagliflozin; Rosiglitazone; Pioglitazone; Liraglutide | Details |
| S05 | Anti-inflammatory | inflammatory | Bile acid; TNF-a inhibitor; Dual PPAR-α and -δ agonists; Toll-Like Receptor; (TLR)-4 antagonist; Caspase inhibitor; ASK-1 inhibitor | Ursodeoxycholic Acid; Pentoxifylline; Elafibranor; JKB-121; Emricasan; Selonsertib; | Details |
| Diseases ID | DO ID | Disease Name | Definition | Class | |
|---|---|---|---|---|---|
| I05 | 9352 | Type 2 diabetes mellitus | A diabetes that is characterized by chronic hyperglycaemia with disturbances of carbohydrate, fat and protein metabolism resulting from defects in insulin secretion, insulin action, or both. A diabetes mellitus that is characterized by high blood sugar, insulin resistance, and relative lack of insulin. http://en.wikipedia.org/wiki/Diabetes, http://en.wikipedia.org/wiki/Diabetes_mellitus_type_2 | disease of metabolism/inherited metabolic disorder/ carbohydrate metabolic disorder/glucose metabolism disease/diabetes/ diabetes mellitus | Details |